Skip to main content

Table 1 Antibodies used for immunohistochemical staining

From: Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas

Factor Antibody Companya Dilution Scoring Cutoff
HER2 NCL-CB 11 Novocastra 1:40 0, 1, 2, 3 ≥ 2+
Top IIa Ab1, clone SWT3D1 Oncogene 1:40 % stained cells >10%
Ki 67 Ki 67, clone MIB-1 Dako 1:100 % stained cells >0%
p53 p53, clone DO-7 Dako 1:200 % stained cells >5%
  1. HER2, human epithelial growth factor receptor 2; Top IIa, topoisomerase IIα.
  2. aNovocastra, Newcastle upon Tyne, UK; Oncogene, Cambridge, MA, USA; DAKO, Hamburg, Germany